Arrowhead Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Anzalone Christopher Richard unloaded Company’s shares for reported $3.01 million on Mar 03 ’25. In the deal valued at $18.03 per share,166,667 shares were sold. As a result of this transaction, Anzalone Christopher Richard now holds 3,907,135 shares worth roughly $59.43 million.
Then, Anzalone Christopher Richard sold 133,333 shares, generating $2,269,328 in total proceeds. Upon selling the shares at $17.02, the Chief Executive Officer now owns 3,773,802 shares.
Before that, Anzalone Christopher Richard bought 133,333 shares. Arrowhead Pharmaceuticals Inc shares valued at $2,268,742 were divested by the Officer at a price of $17.02 per share.
Goldman initiated its Arrowhead Pharmaceuticals Inc [ARWR] rating to a Neutral in a research note published on June 05, 2024; the price target was $31. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Citigroup began covering ARWR with “Neutral” recommendation on September 19, 2023. TD Cowen started covering the stock on July 21, 2023. It rated ARWR as “an Outperform”.
Price Performance Review of ARWR
On Monday, Arrowhead Pharmaceuticals Inc [NASDAQ:ARWR] saw its stock fall -10.37% to $15.21. Over the last five days, the stock has lost -14.12%. Arrowhead Pharmaceuticals Inc shares have fallen nearly -19.10% since the year began. Nevertheless, the stocks have fallen -57.03% over the past one year. While a 52-week high of $35.47 was reached on 02/07/25, a 52-week low of $16.57 was recorded on 03/10/25. SMA at 50 days reached $19.29, while 200 days put it at $22.11.
Levels Of Support And Resistance For ARWR Stock
The 24-hour chart illustrates a support level at 14.59, which if violated will result in even more drops to 13.96. On the upside, there is a resistance level at 16.35. A further resistance level may holdings at 17.49. The Relative Strength Index (RSI) on the 14-day chart is 28.73, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.91, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.31%. Stochastics %K at 11.12% indicates the stock is a buying.
